Magnet recognition is considered a leading source for measuring organizational success in nursing. Magnet hospitals show higher job satisfaction and lower odds of patient mortality than non-Magnet hospitals. However, only nine percent of American hospitals are recognized as Magnet. Currently, there is little research into the causes of the differences between Magnet and non-Magnet hospitals, research that could create an infrastructure for positive change in nurse and patient outcomes.
Poor food choices, such as overconsumption of carbonated soft drinks, are an important factor driving the global obesity epidemic and have been linked directly to diabetes and heart disease. While public health agencies are working to help people to make healthier choices, monitoring the effectiveness of these efforts has been costly and difficult. But now, using the same digital data employed by marketers to promote food products, McGill University's David Buckeridge has developed a way for health agencies to track Montreal consumers' food choices, neighborhood by neighborhood.
Computed tomography (CT) scans routinely taken to guide the treatment of pancreatic cancer may provide an important secondary benefit. According to new research from The University of Texas MD Anderson Cancer Center, the scans also reflect how well chemotherapy will penetrate the tumor, predicting the effectiveness of treatment.
Elsewhere, some business groups enlist help to get their states to expand the program. Also, HHS Secretary Kathleen Sebelius urges Georgia's governor to accept the expansion, which also makes news in New Hampshire and Utah.
Traumatic brain injury is a risk factor for epilepsy, though the relationship is not understood. A new study in mice, published in Cerebral Cortex, identifies increased levels of a specific neurotransmitter as a contributing factor connecting traumatic brain injury (TBI) to post-traumatic epilepsy. The findings suggest that damage to brain cells called interneurons disrupts neurotransmitter levels and plays a role in the development of epilepsy after a traumatic brain injury.
Melbourne scientists are a step closer to creating a new drug to stop a heart attack in its tracks and reduce the damage caused, without any side effects.
First on top of the world and then in the depths of despair - this is what the extreme mood changes for people with bipolar disorder are like. Under the direction of scientists from Bonn, Mannheim and Basel, an international collaboration of researchers discovered two new gene regions that are connected to the prevalent disease. In addition, they were able to confirm three additional suspect genes.
OBiS releases preliminary results from its 2014 global physician breast cancer survey. The survey included treatment data and insights from over 50 countries and 500 treating physicians.
WiserTogether, Inc., a cloud-based, consumer-focused, health decision-making platform, today announced it has entered into a partnership with Truven Health Analytics, a leading provider of healthcare data and analytics solutions and services. The partnership enables Truven Health Analytics and WiserTogether to provide employers and healthcare plans with a unique set of solutions to help their consumers make better healthcare decisions.
According to a Gallup survey released Monday, the health law appears to be reaching its central goal -- reducing the number of Americans without insurance. But NBC News reports that Latinos continue to be more likely to be uninsured than white or black Americans.
Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).
Clinipace Worldwide, a global digital contract research organization (dCRO), announced today the closing of its merger with Choice Pharma, a Pan-Asian contract research organization. Bringing these organizations together strengthens Clinipace Worldwide's operational and therapeutic expertise in Asia, a region in high demand by Clinipace's clients.
QuadraMed Corporation is pleased to announce the General Availability of the next major version of its enterprise EHR solution, QuadraMed Computerized Patient Record. QCPR version 6.0 provides key capabilities and improvements that help organizations provide high-quality and efficient care; meet pressing Canadian, as well as U.S. governmental and industry regulations; and deliver better patient safety, patient engagement, data security, and privacy while being fully interoperable.
Hi-Tech Pharmacal Co., Inc. today reported results for the third fiscal quarter ended January 31, 2014.
NextImage Medical, a leading provider of specialized cost containment services to the workers' compensation industry, today announced that it has completed the purchase of WorkWell, Inc. The individual company product lines will continue to operate under their respective names. Liz Griggs, Chairman and CEO of NextImage Medical, will become the CEO of the combined entity. The financial terms of the acquisition were not made public.
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company's proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.
Almost Family, Inc., a leading regional provider of home health nursing and personal care services, announced today its financial results for the three months and full year ended December 31, 2013.
A new study released today at a meeting of the American Medical Rehabilitation Providers Association (AMRPA) shows that patients treated in inpatient rehabilitation hospitals and units had better long-term clinical outcomes than those treated in nursing homes.
Kindred Healthcare, Inc. today announced that it intends to undertake a refinancing of its existing secured indebtedness. The proposed refinancing would extend the maturity profile of the Company's long-term debt, increase total availability under the Company's secured facilities, improve pricing and provide additional covenant flexibility.